Facebook tracking pixelEnterovesical Fistula - AI-Powered ICD-10 Documentation
N32.1
ICD-10-CM
Enterovesical Fistula

Understanding Enterovesical Fistula, also known as Colovesical Fistula, Vesicointestinal Fistula, or Ileovesical Fistula. This resource provides information on diagnosis, clinical documentation, and medical coding for Enterovesical Fistula. Learn about symptoms, treatment options, and healthcare considerations related to this condition. Find accurate medical coding terms for proper documentation and billing.

Also known as

Colovesical Fistula
Vesicointestinal Fistula
Ileovesical Fistula

Diagnosis Snapshot

Key Facts
  • Definition : Abnormal connection between the bowel and bladder.
  • Clinical Signs : Pneumaturia, fecaluria, recurrent UTIs, abdominal pain.
  • Common Settings : Diverticulitis, Crohn's disease, cancer, radiation therapy.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC N32.1 Coding
N32.1

Vesicointestinal fistula

Abnormal connection between bladder and intestine.

K63.2

Fistula of intestine

Abnormal passage between intestines and other organs.

N30.89

Other disorders of bladder

Includes other specified bladder conditions like fistulas.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is fistula between bowel and bladder?

  • Yes

    Specific bowel segment involved?

  • No

    Do NOT code as Enterovesical Fistula. Review documentation for alternative diagnosis.

Code Comparison

Related Codes Comparison

When to use each related code

Description
Abnormal connection between bowel and bladder.
Abnormal connection between colon and bladder.
Abnormal connection between ileum and bladder.

Documentation Best Practices

Documentation Checklist
  • Document fistula location (e.g., ileovesical, colovesical).
  • Confirm diagnosis with imaging (e.g., CT, MRI).
  • Describe presenting symptoms (e.g., pneumaturia, fecaluria).
  • Document surgical intervention if performed.
  • Specify any related infections (e.g., UTI).

Coding and Audit Risks

Common Risks
  • Fistula Site Specificity

    Coding requires specific documentation of the fistula location (e.g., colovesical, ileovesical) for accurate code assignment and reimbursement.

  • Underlying Cause Coding

    Coding and auditing must capture the underlying etiology of the fistula (e.g., Crohn's disease, diverticulitis) for proper severity and risk adjustment.

  • Complication Coding

    Associated complications (e.g., sepsis, abscess) must be documented and coded separately for accurate reflection of patient acuity and resource utilization.

Mitigation Tips

Best Practices
  • ICD-10 N64.0, CDI: Document fistula location, etiology.
  • CPT 51900, clear op report, compliant billing.
  • Timely diagnosis via cystoscopy, imaging, urinalysis.
  • Surgical repair, bowel management crucial, monitor post-op.
  • Interdisciplinary approach: Urology, GI, ID reduces risks.

Clinical Decision Support

Checklist
  • Confirm pneumaturia, fecaluria, or recurrent UTIs documented (ICD-10 N30.1)
  • Review abdominal imaging (CT/MRI) for fistula tract visualization (CPT 74178)
  • Evaluate colonoscopy/cystoscopy findings for fistula confirmation (CPT 45380/52000)
  • Assess patient history for Crohn's, diverticulitis, or prior pelvic surgery
  • Check UA for fecal matter and urine culture for mixed flora (LOINC 14936-9/10894-5)

Reimbursement and Quality Metrics

Impact Summary
  • Enterovesical Fistula (ICD-10-CM N32.1) reimbursement hinges on accurate coding, impacting hospital revenue cycle management.
  • Coding Colovesical, Vesicointestinal, or Ileovesical Fistula correctly affects Case Mix Index (CMI) and quality reporting.
  • Accurate E-codes for underlying causes of Enterovesical Fistula are crucial for appropriate MS-DRG assignment and reimbursement.
  • Precise documentation and coding of Enterovesical Fistula complications influence hospital quality metrics and value-based payments.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective diagnostic approaches for differentiating between Enterovesical Fistula subtypes (e.g., Colovesical, Ileovesical, Vesicointestinal)?

A: Differentiating between Enterovesical Fistula subtypes, such as Colovesical, Ileovesical, or Vesicointestinal fistulas, requires a multi-modal approach. While patient history (e.g., history of diverticulitis suggesting Colovesical fistula, Crohn's disease suggesting Ileovesical) can provide initial clues, imaging studies are crucial. CT with oral and rectal contrast is often the first line, helping visualize the fistula tract and identify the involved bowel segment. Cystoscopy can directly visualize the fistula opening within the bladder and obtain biopsies to rule out malignancy. Barium studies, though less commonly used now, can further delineate the fistula tract. In complex cases, MRI may provide additional anatomical detail. Explore how combining imaging modalities and clinical history leads to accurate subtype differentiation and targeted treatment planning. Consider implementing a standardized diagnostic pathway for suspected Enterovesical Fistulas to ensure consistent and efficient evaluation.

Q: How do I manage an Enterovesical Fistula in a patient with multiple comorbidities, considering surgical and non-surgical approaches?

A: Managing an Enterovesical Fistula in patients with multiple comorbidities requires careful consideration of the patient's overall health status and the fistula's characteristics (size, location, cause). While surgical repair is often the definitive treatment, a non-surgical approach may be considered for small, asymptomatic fistulas, particularly in high-risk surgical candidates. This might include bowel rest, broad-spectrum antibiotics to manage infection, and nutritional support. However, for larger, symptomatic fistulas (e.g., recurrent UTIs, fecaluria), or those failing conservative management, surgery becomes necessary. Surgical options include open, laparoscopic, or robotic approaches, often involving resection of the affected bowel segment and bladder repair. Preoperative optimization of comorbidities is crucial to minimize surgical risks. Learn more about the latest advancements in minimally invasive surgical techniques for Enterovesical Fistula repair and how these can be adapted for complex patients.

Quick Tips

Practical Coding Tips
  • Code fistula location, e.g., colon, ileum
  • ICD-10 N32.1 for Enterovesical
  • Document fistula cause, e.g., Crohn's
  • Confirm with imaging reports
  • Query physician for clarity if needed

Documentation Templates

Patient presents with symptoms suggestive of an enterovesical fistula, including pneumaturia, fecaluria, recurrent urinary tract infections (UTIs), and abdominal pain.  Differential diagnosis includes diverticulitis, Crohn's disease, bladder cancer, and radiation cystitis.  Physical examination may reveal tenderness in the lower abdomen.  Laboratory findings may demonstrate pyuria, bacteriuria, and potentially positive urine cultures for enteric organisms.  Imaging studies, such as CT scan with oral and rectal contrast, cystoscopy, or colonoscopy, are crucial for confirming the diagnosis of enterovesical fistula and identifying the underlying etiology.  Management of enterovesical fistula often requires surgical intervention, such as bowel resection, fistula repair, and potentially bladder reconstruction.  Conservative management with antibiotics may be considered in select cases but is typically not definitive.  Patient education regarding postoperative care, including wound management and dietary modifications, is essential.  ICD-10 code N32.1 is appropriate for this diagnosis.  This documentation supports medical billing and coding accuracy for enterovesical fistula, colovesical fistula, vesicointestinal fistula, and ileovesical fistula.  Follow-up care includes monitoring for recurrence, managing potential complications such as sepsis or abscess formation, and addressing ongoing urinary symptoms.